List of Tables
Table 1. Global Probenecid Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Probenecid Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Probenecid Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Probenecid Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Probenecid Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Probenecid Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Probenecid Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Probenecid Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Probenecid Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Probenecid Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Probenecid Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Probenecid Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Probenecid Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Probenecid Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Probenecid Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Probenecid Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Probenecid Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Probenecid Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Probenecid Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Probenecid Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Probenecid Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Probenecid Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Probenecid Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Probenecid Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Probenecid Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Probenecid Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Probenecid Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Probenecid Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Probenecid Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Probenecid Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Probenecid Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Probenecid Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Probenecid Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Probenecid Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Probenecid Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Probenecid Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Probenecid Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Probenecid Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Probenecid Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Probenecid Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Probenecid Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Probenecid Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Probenecid Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Probenecid Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Probenecid Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Probenecid Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Probenecid Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Probenecid Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Probenecid Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Probenecid Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Probenecid Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Probenecid Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Probenecid Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Probenecid Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Probenecid Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Probenecid Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Probenecid Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Probenecid Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Probenecid Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Probenecid Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Probenecid Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Probenecid Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Probenecid Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Probenecid Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Probenecid Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Probenecid Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Probenecid Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Probenecid Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Lannett Company Company Information
Table 71. Lannett Company Description and Business Overview
Table 72. Lannett Company Probenecid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Lannett Company Probenecid Tablets Product
Table 74. Lannett Company Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Probenecid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Teva Probenecid Tablets Product
Table 79. Teva Recent Developments/Updates
Table 80. Rising Pharma Company Information
Table 81. Rising Pharma Description and Business Overview
Table 82. Rising Pharma Probenecid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Rising Pharma Probenecid Tablets Product
Table 84. Rising Pharma Recent Developments/Updates
Table 85. Watson Pharmaceuticals Company Information
Table 86. Watson Pharmaceuticals Description and Business Overview
Table 87. Watson Pharmaceuticals Probenecid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Watson Pharmaceuticals Probenecid Tablets Product
Table 89. Watson Pharmaceuticals Recent Developments/Updates
Table 90. Geno Pharmaceuticals Company Information
Table 91. Geno Pharmaceuticals Description and Business Overview
Table 92. Geno Pharmaceuticals Probenecid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Geno Pharmaceuticals Probenecid Tablets Product
Table 94. Geno Pharmaceuticals Recent Developments/Updates
Table 95. Salvavidas Pharmaceutical Company Information
Table 96. Salvavidas Pharmaceutical Description and Business Overview
Table 97. Salvavidas Pharmaceutical Probenecid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Salvavidas Pharmaceutical Probenecid Tablets Product
Table 99. Salvavidas Pharmaceutical Recent Developments/Updates
Table 100. Sunflower Pharmaceutical Group Company Information
Table 101. Sunflower Pharmaceutical Group Description and Business Overview
Table 102. Sunflower Pharmaceutical Group Probenecid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sunflower Pharmaceutical Group Probenecid Tablets Product
Table 104. Sunflower Pharmaceutical Group Recent Developments/Updates
Table 105. Jinling Pharmaceutical Company Information
Table 106. Jinling Pharmaceutical Description and Business Overview
Table 107. Jinling Pharmaceutical Probenecid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Jinling Pharmaceutical Probenecid Tablets Product
Table 109. Jinling Pharmaceutical Recent Developments/Updates
Table 110. Shanghai Sine Pharmaceutical Company Information
Table 111. Shanghai Sine Pharmaceutical Description and Business Overview
Table 112. Shanghai Sine Pharmaceutical Probenecid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Shanghai Sine Pharmaceutical Probenecid Tablets Product
Table 114. Shanghai Sine Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Probenecid Tablets Distributors List
Table 118. Probenecid Tablets Customers List
Table 119. Probenecid Tablets Market Trends
Table 120. Probenecid Tablets Market Drivers
Table 121. Probenecid Tablets Market Challenges
Table 122. Probenecid Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Probenecid Tablets
Figure 2. Global Probenecid Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Probenecid Tablets Market Share by Type: 2025 & 2032
Figure 4. 0.25g per Tablet Product Picture
Figure 5. 0.50g per Tablet Product Picture
Figure 6. Global Probenecid Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Probenecid Tablets Market Share by Application: 2025 & 2032
Figure 8. Hospitals and Clinics
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Probenecid Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Probenecid Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Probenecid Tablets Sales (K Units), 2021–2032
Figure 14. Global Probenecid Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Probenecid Tablets Report Years Considered
Figure 16. Probenecid Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Probenecid Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Probenecid Tablets Players: Market Share by Revenue in Probenecid Tablets in 2025
Figure 19. Probenecid Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Probenecid Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Probenecid Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Probenecid Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Probenecid Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Probenecid Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Probenecid Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Probenecid Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Probenecid Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Probenecid Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Probenecid Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Probenecid Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Probenecid Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Probenecid Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Probenecid Tablets by Type (2021–2032)
Figure 54. Global Probenecid Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Probenecid Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Probenecid Tablets by Application (2021–2032)
Figure 57. Global Probenecid Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Probenecid Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
